Zdrowie i gospodarka · 28/11/2017

FDA Hosts Public Workshop on Variant Classification and Interpretation in Precision Oncology

The Food and Drug Administration (FDA) is hosting a public workshop to gather input from oncology experts on how to effectively assess evidence for classifying and interpreting genetic sequencing results in precision cancer treatment.